Designer antiandrogens join the race against drug resistance
oleh: Jatinder S Josan, John A Katzenellenbogen
| Format: | Article |
|---|---|
| Diterbitkan: | eLife Sciences Publications Ltd 2013-04-01 |
Deskripsi
By using in silico models of the complexes formed by analogues of a cancer drug and its receptor, it may be possible to strategically redesign existing drugs and win the race against mutations that lead to drug resistance in prostate cancer.